AIチャット
Loading data for TRUMY — first visit, this takes a few seconds.

Terumo Corporation

TRUMY · OTC Markets OTCPK · USD

14.67 -0.31 (-2.07%)

終値時点: Sep 14, 2026, 7:57 PM

時価総額
$21.62B
出来高
11.8K

Terumo Corporation(TRUMY)の株価・分析・データ

本質的価値

本源的価値を読み込み中…

アナリスト予想

株価予想 →

アナリスト予測は利用できません

12か月目標株価 · アナリストn/a人

アナリストのコンセンサス: n/a

間隔:1D
ローソク足とシグナルを読み込み中…

業績

財務情報を見る →

読み込み中...

最新決算

実績予想との差前年比
売上高n/an/a
EPS(TTM)n/an/a

次回決算

取引時間中の予定です。

予想 · アップグレード →

決算の詳細を見る →

事業指標

買気配
14.69
純利益(TTM)
164B
0.23
0.6
24.43
n/a
PBR(TTM)
2.15
PSR(TTM)
0.02
決算発表日
Nov 11, 2026
売気配
14.72
出来高
11,844
平均出来高(20日)
106,359
始値
14.75
前日終値
14.98
当日レンジ
14.67 - 14.76
52週レンジ
12.08 - 18.04
配当
$0.19 (1.29%)
権利落ち日
Mar 31, 2026

Terumo Corporationについて

企業情報を見る →
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan. Medical Devices · Healthcare

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.

セクター Healthcare
IPO日 Jan 5, 2010
従業員数 n/a
上場取引所 OTC Markets OTCPK
ティッカー TRUMY
ウェブサイト https://www.terumo.com